On this episode of CANCER BUZZ, we discuss how healthcare providers and policymakers can work together to pave the future of telehealth beyond the current public health emergency.
Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, or wherever you get your podcasts!
Long lagging in acceptance from providers, payers, and patients, telehealth has undergone a renaissance in 2020, enabling millions of people to receive healthcare in the safety of their homes when it was too dangerous to venture outside. Now that the genie is out of the bottle, the healthcare industry wants to know: What is the future of telehealth in a post-pandemic world?
In this episode of CANCER BUZZ, we discuss how healthcare providers and policymakers can work together to pave the future of telehealth beyond the current public health emergency. Now that the barriers to telehealth have tumbled on an unprecedented scale, it’s doubtful future healthcare delivery will maintain the status quo.
Guest: Frank Micciche, Vice President, Public Policy & External Relations, National Committee for Quality Assurance (NCQA)
Related Content:
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
June 30, 2026
Understanding both the benefits to be had from offering BsAb therapy to its community and the scope of this undertaking, Vanderbilt-Ingram Cancer Center took a novel approach with its APP-led BsAb step-up dosing clinic, which won the program a 2026 ACCC Innovator Award.
